Publication:
Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Simple item page
dc.contributor.coauthorFizazi, K.
dc.contributor.coauthorAttard, G.
dc.contributor.coauthorAzad, A.A.
dc.contributor.coauthorBaciarello, G.
dc.contributor.coauthorBeltran, H.
dc.contributor.coauthorBjartell, A.
dc.contributor.coauthorBlanchard, P.
dc.contributor.coauthorBossaert, F.
dc.contributor.coauthorCastro, E.
dc.contributor.coauthorCompérat, E.
dc.contributor.coauthorde Bono, J.
dc.contributor.coauthorDeschamps, A.
dc.contributor.coauthorEfstathiou, E.
dc.contributor.coauthorEmmett, L.
dc.contributor.coauthorFanti, S.
dc.contributor.coauthorFonteyne, V.
dc.contributor.coauthorGonzález-Del-Alba, A.
dc.contributor.coauthorGravis, G.
dc.contributor.coauthorJames, N.D.
dc.contributor.coauthorKanesvaran, R.
dc.contributor.coauthorMcDermott, R.S.
dc.contributor.coauthorMehra, N.
dc.contributor.coauthorParker, C.
dc.contributor.coauthorRenard-Penna, R.M.
dc.contributor.coauthorRubin, M.A.
dc.contributor.coauthorSaad, F.
dc.contributor.coauthorSweeney, C.
dc.contributor.coauthorTombal, B.
dc.contributor.coauthorTree, A.C.
dc.contributor.coauthorWalz, J.
dc.contributor.coauthorZilli, T.
dc.contributor.coauthorGillessen, S.
dc.contributor.coauthorESMO Guidelines Committee
dc.contributor.departmentKUH (Koç University Hospital)
dc.contributor.kuauthorTilki, Derya
dc.contributor.schoolcollegeinstituteKUH (KOÇ UNIVERSITY HOSPITAL)
dc.date.accessioned2026-07-02T07:02:25Z
dc.date.available2026-03-27
dc.date.issued2026
dc.description.abstractThis ESMO Clinical Practice Guideline (CPG) focuses on advanced and metastatic prostate cancer. This includes metastatic castration-sensitive prostate cancer (mCSPC), non-metastatic castration-resistant prostate cancer (nmCRPC) and metastatic castration-resistant prostate cancer (mCRPC). The management of early-stage disease is covered in the ESMO CPG for local and locoregional prostate cancer.
dc.description.fulltextNo
dc.description.harvestedfromManual
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.publisherscopeInternational
dc.description.readpublishN/A
dc.description.sponsoredbyTubitakEuN/A
dc.description.versionPublished Version
dc.identifier.WoSQuartileQ1
dc.identifier.doi10.1016/j.annonc.2026.01.015
dc.identifier.eissn1569-8041
dc.identifier.embargoNo
dc.identifier.endpage607
dc.identifier.issn0923-7534
dc.identifier.issue5
dc.identifier.pubmed41679466
dc.identifier.scopus2-s2.0-105031167297
dc.identifier.startpage590
dc.identifier.urihttps://doi.org/10.1016/j.annonc.2026.01.015
dc.identifier.urihttps://hdl.handle.net/20.500.14288/32781
dc.identifier.volume37
dc.identifier.wos001749061000001
dc.keywordsAdvanced prostate cancer
dc.keywordsCastration resistant
dc.keywordsCastration sensitive
dc.keywordsDiagnosis
dc.keywordsGuideline
dc.keywordsTreatment
dc.languageeng
dc.publisherElsevier
dc.relation.affiliationKoç University
dc.relation.collectionKoç University Institutional Repository
dc.relation.ispartofAnnals of Oncology
dc.relation.openaccessN/A
dc.rightsN/A
dc.rights.uriN/A
dc.subjectOncology
dc.titleAdvanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
dc.typeJournal Article
dspace.entity.typePublication
relation.isOrgUnitOfPublicationf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isOrgUnitOfPublication.latestForDiscoveryf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isParentOrgUnitOfPublication055775c9-9efe-43ec-814f-f6d771fa6dee
relation.isParentOrgUnitOfPublication.latestForDiscovery055775c9-9efe-43ec-814f-f6d771fa6dee

Files

Collections

Publications without Fulltext